Abstract
Subsequent to the discovery of 4-[(2,4-dichlorophenyl)amino]-6,7-dimethoxy-3-quinolinecarbonitrile (1a) as an inhibitor of Src kinase activity (IC(50) = 30 nM), several additional analogues were prepared. Optimization of the C-4 anilino group of 1a led to 1c, which contains a 2,4-dichloro-5-methoxy-substituted aniline. Replacement of the methoxy group at C-7 of 1c with a 3-(morpholin-4-yl)propoxy group provided 2c, resulting in increased inhibition of both Src kinase activity and Src-mediated cell proliferation. Analogues of 2c with other trisubstituted anilines at C-4 were also potent Src inhibitors, and the propoxy group of 2c was preferred over ethoxy, butoxy, or pentoxy. Replacement of the morpholine group of 2c with a 4-methylpiperazine group provided 31a, which had an IC(50) of 1.2 nM in the Src enzymatic assay, an IC(50) of 100 nM for the inhibition of Src-dependent cell proliferation and was selective for Src over non-Src family kinases. Compound 31a, which had higher 1 and 4 h plasma levels than 2c, effectively inhibited tumor growth in xenograft models.
MeSH terms
-
Animals
-
Antineoplastic Agents / chemical synthesis*
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / pharmacokinetics
-
Antineoplastic Agents / pharmacology
-
Cell Division / drug effects
-
Cell Line, Transformed
-
Enzyme Inhibitors / chemical synthesis*
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / pharmacokinetics
-
Enzyme Inhibitors / pharmacology
-
Female
-
Fibroblasts / metabolism
-
Humans
-
Immunoblotting
-
Mice
-
Mice, Inbred BALB C
-
Mice, Nude
-
Nitriles / chemical synthesis*
-
Nitriles / chemistry
-
Nitriles / pharmacokinetics
-
Nitriles / pharmacology
-
Phosphorylation
-
Piperazines / chemical synthesis*
-
Piperazines / chemistry
-
Piperazines / pharmacokinetics
-
Piperazines / pharmacology
-
Quinolines / chemical synthesis*
-
Quinolines / chemistry
-
Quinolines / pharmacokinetics
-
Quinolines / pharmacology
-
Structure-Activity Relationship
-
Tumor Cells, Cultured
-
Tyrosine / metabolism
-
Xenograft Model Antitumor Assays
-
src-Family Kinases / antagonists & inhibitors*
Substances
-
4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-3-quinolinecarbonitrile
-
Antineoplastic Agents
-
Enzyme Inhibitors
-
Nitriles
-
Piperazines
-
Quinolines
-
Tyrosine
-
src-Family Kinases